285 results on '"Loussouarn, Delphine"'
Search Results
2. Deep Learning for Detecting BRCA Mutations in High-Grade Ovarian Cancer Based on an Innovative Tumor Segmentation Method From Whole Slide Images
3. Diagnostic des sarcomes utérins et tumeurs mésenchymateuses utérines rares à potentiel de malignité. Référentiels du Groupe Sarcome Français et des Tumeurs Rares Gynécologiques
4. Cardiomyopathies inflammatoires : diagnostic, corrélations avec l’imagerie, intérêt de la biopsie myocardique et place de la biologie moléculaire
5. Meningiomas and cyproterone acetate: a retrospective, monocentric cohort of 388 patients treated by surgery or radiotherapy for intracranial meningioma
6. Phenotypic discordance between primary and metastatic breast cancer in the large-scale real-life multicenter French ESME cohort
7. Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study
8. Deep Learning Methodologies Applied to Digital Pathology in Prostate Cancer: A Systematic Review
9. Spatial Distribution of Immune Cells in Primary and Recurrent Glioblastoma: A Small Case Study
10. Diagnostic des sarcomes utérins et tumeurs mésenchymateuses utérines rares à potentiel de malignité. Référentiels du Groupe Sarcome Français et des Tumeurs Rares Gynécologiques
11. STING-dependent paracriny shapes apoptotic priming of breast tumors in response to anti-mitotic treatment
12. Androgen receptor and FOXA1 coexpression define a “luminal-AR” subtype of feline mammary carcinomas, spontaneous models of breast cancer
13. CD8+ T cell-mediated endotheliopathy is a targetable mechanism of neuro-inflammation in Susac syndrome
14. Bcl-2 expression and prognostic significance in feline invasive mammary carcinomas: a retrospective observational study
15. Figure S6 from Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity
16. Supplementary Tables from Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity
17. Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors
18. Canine invasive mammary carcinomas as models of human breast cancer. Part 2: immunophenotypes and prognostic significance
19. Tumeurs fibreuses solitaires et hémangiopéricytomes des méninges : immunophénotype et évaluation du grade histopronostique dans 17 cas
20. Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
21. Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group
22. Mise à jour 2014 des recommandations du GEFPICS pour l’évaluation du statut HER2 dans les cancers du sein en France
23. Recommandations du GEFPICS concernant la phase pré-analytique pour l’évaluation de HER2 et des récepteurs hormonaux dans le cancer du sein : mise à jour 2014
24. Pharmacological targeting of apelin impairs glioblastoma growth
25. A Multigene Signature Associated with Progression-Free Survival after Treatment for IDH Mutant and 1p/19q Codeleted Oligodendrogliomas.
26. Prognostic value of hPG80 (circulating progastrin) in IDH-wild type glioblastoma treated with radio-chemotherapy.
27. Tumor cells with neuronal intermediate progenitor features define a subgroup of 1p/19q co‐deleted anaplastic gliomas
28. Folate supplementation limits the tumourigenesis in rodent models of gliomagenesis
29. A Convenient Route to New (Radio)Fluorinated and (Radio)Iodinated Cyclic Tyrosine Analogs
30. A phase II randomised study of preoperative trastuzumab alone or combined with everolimus in patients with early HER2-positive breast cancer and predictive biomarkers (RADHER trial)
31. Margin Width Should Not Still Enforce a Systematic Surgical Re-excision in the Conservative Treatment of Early Breast Infiltrative Ductal Carcinoma
32. Prognostic Relevance of Histomolecular Classification of Diffuse Adult High-Grade Gliomas with Necrosis
33. Syndecan-1 antigen, a promising new target for triple-negative breast cancer immuno-PET and radioimmunotherapy. A preclinical study on MDA-MB-468 xenograft tumors
34. Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods
35. ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis
36. Supplementary_methods_1 – Supplemental material for Identification of an immune-suppressed subtype of feline triple-negative basal-like invasive mammary carcinomas, spontaneous models of breast cancer
37. Photodynamic effects of SIM01, a new sensitizer, on experimental brain tumors in rats
38. Validation of tumor-associated macrophage ferritin light chain as a prognostic biomarker in node-negative breast cancer tumors: A multicentric 2004 national PHRC study
39. One‐year conditional survival of dogs and cats with invasive mammary carcinomas: A concept inspired from human breast cancer
40. Identification of an immune-suppressed subtype of feline triple-negative basal-like invasive mammary carcinomas, spontaneous models of breast cancer
41. Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study
42. Proposal for a Histological Staging System of Mammary Carcinomas in Dogs and Cats. Part 1: Canine Mammary Carcinomas
43. Proposal for a Histological Staging System of Mammary Carcinomas in Dogs and Cats. Part 2: Feline Mammary Carcinomas
44. PDTM-24. PINEOBLASTOMA SEGREGATES INTO MOLECULAR SUBTYPES WITH DISTINCT CLINICOPATHOLOGIC FEATURES: REPORT FROM THE RARE BRAIN TUMOUR CONSORTIUM
45. Combined chemotherapy and allogeneic human Vγ9Vδ2 T lymphocyte-immunotherapies efficiently control the development of human epithelial ovarian cancer cells in vivo
46. Additional file 18: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
47. Additional file 29: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
48. Additional file 5: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
49. Additional file 3: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
50. Additional file 4: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.